Metraipolis › archive › dc_caf09271d677
Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national… — Europe PMC PMID:41676232
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41676232
- DOI
- 10.18632/oncoscience.643
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T01:33:11.683Z
- SHA-256 of the archived text
aef776d5e493005e12b0bbe951e930a6edc5629a1291e58b62f03bbe3045787b- Stable URL of this page
https://metraipolis.com/documento/dc_caf09271d677
How to cite
Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national… — Europe PMC PMID:41676232 — Europe PMC (en), https://europepmc.org/article/MED/41676232 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_caf09271d677 (Metraipolis archive dc_caf09271d677, sha256 aef776d5e493005e12b0bbe951e930a6edc5629a1291e58b62f03bbe3045787b)
BibTeX
@misc{dccaf09271d677,
title = {Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national… — Europe PMC PMID:41676232},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41676232},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_caf09271d677; sha256 aef776d5e493005e12b0bbe951e930a6edc5629a1291e58b62f03bbe3045787b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41676232. Agents can read the archived copy with the MCP tool read_document.